We are live on
!
Find out more
6CM
683 Capital Management Portfolio holdings
AUM
$1.92B
1-Year Est. Return
85.52%
This Fund
S&P 500
This Quarter
Est. Return
+17.29%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.22B
AUM Growth
-$65.3M
(-5.1%)
Cap. Flow
-$208M
Cap. Flow
% of AUM
-16.99%
Top 10 Holdings %
Top 10 Hldgs %
34.8%
Holding
287
New
134
Increased
23
Reduced
46
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BorgWarner
BWA
|
+$20.6M |
| 2 |
Hilton Grand Vacations
HGV
|
+$19M |
| 3 |
Carvana
CVNA
|
+$12.5M |
| 4 |
NCR Atleos
NATL
|
+$9.39M |
| 5 |
Sarepta Therapeutics
SRPT
|
+$6.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enova International
ENVA
|
+$28.6M |
| 2 |
FLG
Flagstar Bank National Association
FLG
|
+$24.5M |
| 3 |
Vistra
VST
|
+$18.3M |
| 4 |
Noble Corp
NE
|
+$16.1M |
| 5 |
Phinia Inc
PHIN
|
+$8.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Consumer Discretionary | 18.74% |
| 3 | Financials | 10.52% |
| 4 | Materials | 4.8% |
| 5 | Industrials | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
51
DELISTED
Apellis Pharmaceuticals
APLS
| $7.78M | 0.64% |
130,000
-110,000
| -46% | -$5.58M |
|
52
KNOT Offshore Partners
KNOP
$363M
| $7.2M | 0.59% |
1,249,219
+102,718
| +9% | +$600K |
|
53
PUT
Bank of America
BAC
$440B
| $6.73M | 0.55% |
200,000
| – | – |
|
54
Teck Resources
TECK
$31.8B
| $6.34M | 0.52% |
150,000
-65,000
| -30% | -$2.5M |
|
|
FYBR
55
DELISTED
Frontier Communications
FYBR
| $6.33M | 0.52% |
250,000
-200,000
| -44% | -$4.04M |
|
|
ARIS
56
Aris Mining
ARIS
$3.04B
| $6.27M | 0.51% |
1,900,000
-415,900
| -18% | -$1.15M |
|
|
57
Phinia Inc
PHIN
$2.93B
| $5.3M | 0.43% |
175,000
-325,000
| -65% | -$8.72M |
|
|
CCTS
58
DELISTED
Cactus Acquisition Corp. 1 Limited Class A Ordinary Share
CCTS
| $4.92M | 0.4% |
450,000
| – | – |
|
59
PUT
Apple
AAPL
$4.52T
| $4.81M | 0.39% |
+25,000
| New | +$4.62M |
|
60
PUT
Caesars Entertainment
CZR
$6.14B
| $4.69M | 0.38% |
100,000
-100,000
| -50% | -$4.44M |
|
|
AFMD
61
DELISTED
Affimed
AFMD
| $4.38M | 0.36% |
700,000
-122,500
| -15% | -$508K |
|
|
FOLD
62
CALL
DELISTED
Amicus Therapeutics
FOLD
| $4.19M | 0.34% |
+295,500
| New | +$3.36M |
|
|
FLG
63
PUT
Flagstar Bank National Association
FLG
$5.95B
| $4.09M | 0.34% |
133,333
| – | – |
|
|
KLG
64
DELISTED
WK Kellogg Co
KLG
| $4.07M | 0.33% |
+310,000
| New | +$3.49M |
|
65
Zevra Therapeutics
ZVRA
$622M
| $3.54M | 0.29% |
+540,800
| New | +$2.53M |
|
|
SLNO
66
DELISTED
Soleno Therapeutics
SLNO
| $3.5M | 0.29% |
87,000
| – | – |
|
67
Globalstar
GSAT
$10.8B
| $3.36M | 0.28% |
115,613
-17,720
| -13% | -$390K |
|
|
CPE
68
DELISTED
Callon Petroleum Company
CPE
| $3.24M | 0.27% |
100,000
-20,000
| -17% | -$685K |
|
69
Gossamer Bio
GOSS
$88.7M
| $3.02M | 0.25% |
3,314,700
+1,588,561
| +92% | +$1.17M |
|
70
Roivant Sciences
ROIV
$25B
| $2.93M | 0.24% |
+261,000
| New | +$2.54M |
|
|
LKFT
71
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.73B
| $2.36M | 0.19% |
58,000
| – | – |
|
72
PUT
Madrigal Pharmaceuticals
MDGL
$11.7B
| $2.31M | 0.19% |
10,000
| – | – |
|
|
73
PUT
BorgWarner
BWA
$12.9B
| $2.22M | 0.18% |
62,000
-38,000
| -38% | -$1.36M |
|
74
Aurinia Pharmaceuticals
AUPH
$1.92B
| $1.98M | 0.16% |
+220,000
| New | +$1.81M |
|
|
HLVX
75
DELISTED
HilleVax
HLVX
| $1.95M | 0.16% |
121,200
| – | – |
|
Similar funds
QOP
RIL
MC
RCAG
BOH
DCM
CC
IAN
683 Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, 683 Capital Management held 287 positions worth $1.22B, down 5.1% from $1.29B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
683 Capital Management withdrew a net $208M in Q4 2023, closing 28 positions and reducing 46 holdings. Its most notable exit was Hess, an estimated $7.65M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, 683 Capital Management opened a new position in NCR Atleos worth $9.96M.
- 683 Capital Management's largest Q4 2023 buy was NCR Atleos: 410,000 shares worth $9.96M.
- 683 Capital Management added most to BorgWarner in Q4 2023, an estimated $20.6M increase.
- 683 Capital Management's biggest Q4 2023 reduction was Enova International, cutting an estimated $28.6M.
- 683 Capital Management fully exited Hess in Q4 2023, selling an estimated $7.65M.
- 683 Capital Management's ten largest holdings make up 35% of its $1.22B portfolio in Q4 2023.
- 683 Capital Management opened 134 new positions and closed 28 in Q4 2023.
- 683 Capital Management's portfolio value fell 5.1% quarter-over-quarter to $1.22B.
Based on 683 Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.